|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Sequence-dependent,synergistic antiproliferative and proapoptic effects of the combination of cytotoxic drugs and enzastaurum,a protein kinase Cβ inhibitor in non-small cell lung cancer cells显示文摘 | Morgillo F Martinelli E Troiani T | 2008 | Mol Cancer Ther2008，17，6： | 1 |
| 2 | Combining trgeted therapies and drugs with multiple targets in the treatment of NSCLC 显示文摘 | Maione P Gridelli C Troiani T | 2006 | Oncologist2006，11，3： | 1 |
| 3 | The use of xenografi models for the selection of cancer treatments with the EGFR as an example显示文摘 | Troiani T Schettino C Martinelli E | 2008 | Crit Rev Oncol Hematol2008，65，3： | 1 |
| 4 | Panitumumab , the evidence of its therapeutic potential in metastatic colorectal cancer care 显示文摘 | Martinelli E Morgillo F Troiani T | 2007 | Core Evid2007，2，2： | 1 |
| 5 | Sequence-dependent anti- proliferative effects of eytotoxic drugand epidermal growth factor receptor in- hibitors 显示文摘 | Morelli M P Cascone T Troiani T | 2005 | Annals of Oncology2005，16，4： | 1 |
| 6 | Anti-tumor activity of the combination of cetuximab, an anti-EGFR blocking monoclonal antibody and ZD6474, an inhibitor of VEGFR and EGFR tyrosine kinases显示文摘 | Morelli MP Cascone T Troiani T | 2006 | J Cell Physiol2006，208，2： | 1 |
| 7 | Erlotinib in cancer treatment 显示文摘 | Bareschino MA Schettino C Troiani T | 2007 | Ann Oncol2007，18，6： | 1 |
| 8 | Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy显示文摘 | Bianco R Troiani T Tortora G | 2005 | Endocr Relat Cancer2005，12，1： | 1 |
| 9 | Erlotinib in cancer treatment显示文摘 | Bareschino MA Schettino C Troiani T | | 0，，6： | 1 |
| 10 | Antitumor activity of ZD6474, a vascular endothelial growth factor -2 and epidermal growth factor receptor small molecule tyrosine kinase inhibitor, in combination with SC - 236, a cyclooxygenase - 2 inhibitor 显示文摘 | Tuccillo C Romano M Troiani T | 2005 | Clin Cancer Res2005，11，： | 1 |
| 11 | Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC显示文摘 | Maione P Gridelli C Troiani T | 2006 | Oncologist2006，11，3： | 1 |
| 12 | Sequence-dependent,synergistic antiproliferative and proapoptotic effects of the combination of cytotoxic drugs and enzastaurin,a protein kinase C beta inhibitor,in non-small cell lung cancer cells 显示文摘 | Morgillo F Martinelli E Troiani T | 2008 | Mol Cancer Ther2008，7，6： | 1 |
| 13 | Antitumor activity of bortezomib in human cancer cells with acquired resistance to anti-epidermal growth factor receptor tyrosine kinase inhibi- tors显示文摘 | Morgillo F Daiuto E Troiani T | 2011 | Lung Cancer2011，71，3： | 1 |
| 14 | Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways:a rational approach for multi-target anticancer therapy显示文摘 | Ciardiello F Troiani T Bianco R | 2006 | Ann Oncol2006，17，7： | 1 |
| 15 | Combining targeted therapies and drugs with multiple targets in the treatment of NSCLC显示文摘 | Maione P Gridelli C Troiani T | 2006 | Oncologist2006，11，3： | 1 |
| 16 | Interaction between the epidermal growth factor receptor (EGFR) and the vascular endothelial growth factor (VEGF) pathways:a rational approach for multitarget anticancer therapy显示文摘 | Troiani T Bianco R | 2006 | Ann Oncol2006，177，： | 1 |
| 17 | 查看详情显示文摘 | Fujitsuka M Hara M Tojo S Okada A Troiani V Solladie N Majima T | | 0，，： | 1 |
| 18 | Sequence dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhihitors 显示文摘 | Morelli MP Cascone T TROIANI T | 2005 | Ann Oncol2005，16，4： | 1 |
| 19 | Phase II study of Lapatinib in combination with docetaxel as first-line therapy in metastatic breast cancer显示文摘 | CIARDIELLO F TROIANI T CAPUTO F | 2006 | Brit J Cancer2006，94，11： | 1 |
| 20 | Intrinsic resistance to selumetinib,a selective inhibitor of MEK1/2,by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells显示文摘 | Troiani T Vecchione L Martinelli E | | 0，，： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员